Table of Content

Table of Contents

Global Equine Rhinopneumonitis Vaccine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Equine Rhinopneumonitis Vaccine Market by Value
2.2.1 Global Equine Rhinopneumonitis Vaccine Revenue by Type
2.2.2 Global Equine Rhinopneumonitis Vaccine Market by Value (%)
2.3 Global Equine Rhinopneumonitis Vaccine Market by Production
2.3.1 Global Equine Rhinopneumonitis Vaccine Production by Type
2.3.2 Global Equine Rhinopneumonitis Vaccine Market by Production (%)

3. The Major Driver of Equine Rhinopneumonitis Vaccine Industry
3.1 Historical & Forecast Global Equine Rhinopneumonitis Vaccine Demand
3.2 Largest Application for Equine Rhinopneumonitis Vaccine (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Equine Rhinopneumonitis Vaccine Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Equine Rhinopneumonitis Vaccine Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Equine Rhinopneumonitis Vaccine Average Price Trend
12.1 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in US (2018-2022)
12.2 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in Europe (2018-2022)
12.3 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in China (2018-2022)
12.4 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in Japan (2018-2022)
12.5 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in India (2018-2022)
12.6 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in Korea (2018-2022)
12.7 Market Price for Each Type of Equine Rhinopneumonitis Vaccine in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Equine Rhinopneumonitis Vaccine Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Equine Rhinopneumonitis Vaccine

14. Equine Rhinopneumonitis Vaccine Competitive Landscape
14.1 Zoetis
14.1.1 Zoetis Company Profiles
14.1.2 Zoetis Product Introduction
14.1.3 Zoetis Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Nisseiken Co., Ltd.
14.2.1 Nisseiken Co., Ltd. Company Profiles
14.2.2 Nisseiken Co., Ltd. Product Introduction
14.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Boehringer Ingelheim
14.3.1 Boehringer Ingelheim Company Profiles
14.3.2 Boehringer Ingelheim Product Introduction
14.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Santa Cruz Animal Health
14.4.1 Santa Cruz Animal Health Company Profiles
14.4.2 Santa Cruz Animal Health Product Introduction
14.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Merck
14.5.1 Merck Company Profiles
14.5.2 Merck Product Introduction
14.5.3 Merck Equine Rhinopneumonitis Vaccine Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Equine Rhinopneumonitis Vaccine Industry (Volume)
Figure 2. Equine Rhinopneumonitis Vaccine Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Equine Rhinopneumonitis Vaccine Revenue in 2022
Figure 5. US Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Equine Rhinopneumonitis Vaccine Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Equine Rhinopneumonitis Vaccine Revenue, by Type (Million USD) (2018-2028)
Table 4. Equine Rhinopneumonitis Vaccine Production, by Type (K Unit) (2018-2028)
Table 5. Equine Rhinopneumonitis Vaccine Demand (K Unit) by Application (2018-2028)
Table 6. Equine Rhinopneumonitis Vaccine Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Equine Rhinopneumonitis Vaccine Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Equine Rhinopneumonitis Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Equine Rhinopneumonitis Vaccine in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Zoetis Profiles
Table 61. Zoetis Equine Rhinopneumonitis Vaccine Product Introduction
Table 62. Zoetis Equine Rhinopneumonitis Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Zoetis Strategic initiatives
Table 64. Nisseiken Co., Ltd. Profiles
Table 65. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Introduction
Table 66. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Nisseiken Co., Ltd. Strategic initiatives
Table 68. Boehringer Ingelheim Profiles
Table 69. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Introduction
Table 70. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Boehringer Ingelheim Strategic initiatives
Table 72. Santa Cruz Animal Health Profiles
Table 73. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Introduction
Table 74. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Santa Cruz Animal Health Strategic initiatives
Table 76. Merck Profiles
Table 77. Merck Equine Rhinopneumonitis Vaccine Product Introduction
Table 78. Merck Equine Rhinopneumonitis Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Merck Strategic initiatives